Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Equity Average (2020 - 2025)

Treace Medical Concepts (TMCI) has disclosed Equity Average for 6 consecutive years, with $88.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 18.95% year-over-year to $88.3 million, compared with a TTM value of $88.3 million through Dec 2025, down 18.95%, and an annual FY2025 reading of $100.1 million, down 20.18% over the prior year.
  • Equity Average was $88.3 million for Q4 2025 at Treace Medical Concepts, down from $93.4 million in the prior quarter.
  • Across five years, Equity Average topped out at $153.8 million in Q2 2023 and bottomed at $46000.0 in Q1 2021.
  • Average Equity Average over 5 years is $97.5 million, with a median of $100.8 million recorded in 2021.
  • Peak annual rise in Equity Average hit 195433.7% in 2022, while the deepest fall reached 35.56% in 2022.
  • Year by year, Equity Average stood at $95.2 million in 2021, then plummeted by 35.56% to $61.4 million in 2022, then soared by 124.72% to $137.9 million in 2023, then fell by 21.03% to $108.9 million in 2024, then fell by 18.95% to $88.3 million in 2025.
  • Business Quant data shows Equity Average for TMCI at $88.3 million in Q4 2025, $93.4 million in Q3 2025, and $101.5 million in Q2 2025.